TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice.
about
The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transitionHMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transitionThe latent transforming growth factor beta binding protein (LTBP) familyEpidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF.Autocrine PDGFR signaling promotes mammary cancer metastasisTransforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanismRadiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor typeSmad7 induces hepatic metastasis in colorectal cancerThe basics of epithelial-mesenchymal transitionTransforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-betaInterfering with TGFbeta-induced Smad3 nuclear accumulation differentially affects TGFbeta-dependent gene expressionSignal processing in the TGF-beta superfamily ligand-receptor networkTGF-β - an excellent servant but a bad masterComplexities of TGF-β targeted cancer therapy.TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and MetastasisTransforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell linesThe Discovery and Early Days of TGF-β: A Historical PerspectiveHealing of burn wounds in transgenic mice overexpressing transforming growth factor-beta 1 in the epidermisImmunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patientsPlatelet P2Y12 is involved in murine pulmonary metastasisThe FYVE domain of Smad Anchor for Receptor Activation (SARA) is required to prevent skin carcinogenesis, but not in mouse developmentSnail blocks the cell cycle and confers resistance to cell deathTGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytesTGF-beta-induced epithelial to mesenchymal transitionCombined proteasome and histone deacetylase inhibition attenuates epithelial-mesenchymal transition through E-cadherin in esophageal cancer cellsSmad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia.Association between TGFBR1*6A and osteosarcoma: a Chinese case-control studyDesmoplasia in different degrees of invasion of carcinoma ex-pleomorphic adenoma.Smad4-mediated TGF-beta signaling in tumorigenesis.Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients.Insights into cancer from transgenic mouse models.Genetic events and the role of TGF beta in epithelial tumour progression.PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis.TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transitionTGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.Stem cells: the intestinal stem cell as a paradigm.
P2860
Q21195231-78D7064F-24C3-4885-AD0D-15FD2200B28CQ24301339-A81CCCB6-5EB9-498A-93AB-B19E1244C6EAQ24318681-A53B5336-3160-4E7C-881C-14DB016C40BCQ24532213-51F81066-7486-4119-ACEE-66AD30317B84Q24540358-506D2035-2884-42E3-B19D-18B9C4DDE9F0Q24545375-13CA961F-2481-43AB-B70E-D52A5D1230CBQ24600173-248A312B-CD1E-4478-9731-33FBFDFA1C28Q24620175-671DEEB7-CA44-4F2C-AE40-CFEB89B7DC2AQ24649660-089C0E95-E629-4268-8638-E989658AE20EQ24652992-3D6F2E0D-B98A-46ED-99B5-84E4FC5C173CQ24793319-A46C31E4-9ED4-4724-92EC-D82F9567D696Q24793548-A0F01469-318A-44F0-BB6A-39896D64C339Q25257731-445C7EDF-6D91-4A1E-8B34-290D624C4FA7Q27025590-B6762936-4A50-48AF-AF2D-056804628EDDQ27693607-CAB57C59-83D4-419E-9A23-E8DB8C8B06C6Q28083107-2CA78E12-A337-42A9-A3DB-398CCD9714F0Q28138728-BB6501C6-7ED9-413F-881A-B5B80E4375F2Q28276556-40DC3CFF-C90B-493E-B576-818E8F7DC32AQ28365742-2A2DB892-82FD-47F8-AB4F-B2FDA06B2346Q28390399-1EA73574-5A31-4F15-A16E-582207A3A98DQ28535093-CC466D46-CE9C-4A79-9B1A-923E391D0A7DQ28542654-4A8F7106-0C59-427D-8B14-64A204C65D2CQ28572344-FC566064-C2AC-477F-8819-D6C08A035340Q28594881-B9A80640-E6A9-43AF-8A5B-117167466967Q29619820-DB2AD9CB-CAEF-4E3C-BDDE-E07CCECF557FQ30409676-CEA74D00-AEC4-420C-8B88-0073ED5E4E78Q30476201-6C8DB881-FA46-4904-8138-5F662190711BQ30482281-C6F5AE02-B789-49D8-BC80-8BAE29F22E3FQ33568163-BEC2B300-0C12-46A2-9E2D-7DD141376041Q33594775-49611619-9896-4C6E-A45E-35251B27A7FAQ33596982-706313B7-4D0C-4377-9DBC-AAA6689A19BFQ33614767-A73CA24D-3D2A-4314-9680-FEC58C7F6740Q33643327-3652EA30-9467-46E8-9EB7-FE545BE8F127Q33643339-8CFD2F11-16AB-469A-958F-7EA4833ADFAFQ33693105-E2689954-2AFC-425F-A4BE-1926B2C2FC48Q33728014-9E2E7D62-BB21-4F83-9B86-F9316ADEB914Q33734595-8FD025D5-27C4-47AC-AB3C-E0285C05CDC3Q33834762-4D157304-7A5C-4810-B5DB-95D88CE93F2BQ33840435-23D8BC2F-190D-4813-8722-831DF89FAFB1Q33846215-FA8145EA-140A-4EA8-8DAA-9C113A8854A2
P2860
TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
TGFbeta1 inhibits the formatio ...... carcinomas in transgenic mice.
@en
TGFbeta1 inhibits the formatio ...... carcinomas in transgenic mice.
@nl
type
label
TGFbeta1 inhibits the formatio ...... carcinomas in transgenic mice.
@en
TGFbeta1 inhibits the formatio ...... carcinomas in transgenic mice.
@nl
prefLabel
TGFbeta1 inhibits the formatio ...... carcinomas in transgenic mice.
@en
TGFbeta1 inhibits the formatio ...... carcinomas in transgenic mice.
@nl
P2093
P1433
P1476
TGFbeta1 inhibits the formatio ...... carcinomas in transgenic mice.
@en
P2093
P304
P356
10.1016/S0092-8674(00)80127-0
P407
P50
P577
1996-08-01T00:00:00Z